Status:
COMPLETED
Transcranial Magnetic Stimulation (rTMS) Accelerates the Response to Escitalopram in Major Depression
Lead Sponsor:
Hillerod Hospital, Denmark
Collaborating Sponsors:
Medicon Valley Academy
Conditions:
Major Depression
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
A doubleblind randomised trial with active versus sham rTMS in combination with escitalopram in patients with prior treatment resistant depression in an acute 12 weeks trial with subsequent 24 weeks s...
Detailed Description
In this study we aimed at investigating to what degree rTMS applied over the left dorsolateral cortex relieves depressive symptoms when the treament is combined with antidepressive medication. The stu...
Eligibility Criteria
Inclusion
- Major depression Hamilton score above 18
- Age 18 to 75
Exclusion
- Pregnancy og breastfeeding
- Mental retardation and organic brain disease
- Alcohol and substance abuse
- Metal implants in brain, pacemakers and other electronic implants
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT00149071
Start Date
March 1 2004
End Date
January 1 2006
Last Update
November 5 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatric research unit, Hilleroed Hospital,
Hillerød, Denmark, 3400